| Structure | Chemical Name | CAS | MF |
|
1H-Benzimidazol-5-ol,2,4,6-trimethyl-(9CI)
|
148832-45-5
|
C10H12N2O
|
|
3,5-(1H)-pyrazoledicarbaldehyde
|
148832-75-1
|
C5H4N2O2
|
|
TERT-BUTYL 1'H-SPIRO[INDENE-1,4'-PIPERIDINE]-1'-CARBOXYLATE
|
148835-99-8
|
C18H25NO2
|
|
(S)-2-(2-BROMOPHENYL)-4-ISOPROPYL-4,5-DIHYDROOXAZOLE
|
148836-24-2
|
C12H14BrNO
|
|
1-BROMO-4-CHLORO-2-IODOBENZENE
|
148836-41-3
|
C6H3BrClI
|
|
ETHYL 4-CHLORO-2,5-DIMETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXYLATE
|
148838-70-4
|
C11H11ClN2O2S
|
|
Hatu
|
148839-10-1
|
|
|
5-CHLORO-2-METHYLPHENYLBORONIC ACID
|
148839-33-2
|
C7H8BClO2
|
|
L-threo-3-Pentulose, 1-deoxy- (9CI)
|
148839-53-6
|
C5H10O4
|
|
2(3H)-Furanone,3-acetyl-5-ethoxydihydro-3,4-dimethyl-,(3alpha,4alpha,5bta)-(9CI)
|
148840-16-8
|
C10H16O4
|
|
2(3H)-Furanone,3-acetyl-5-ethoxydihydro-3,4-dimethyl-,(3alpha,4bta,5bta)-(9CI)
|
148840-17-9
|
C10H16O4
|
|
2(3H)-Furanone,3-acetyl-5-ethoxydihydro-3,4-dimethyl-,(3alpha,4alpha,5alpha)-(9CI)
|
148840-18-0
|
C10H16O4
|
|
3H-2-BENZAZEPIN-3-ONE, 4-AMINO-1,2,4,5-TETRAHYDRO-
|
148842-85-7
|
C10H12N2O
|
|
(S)-BOC-4-AMINO-2-CARBOXYMETHYL-1,3,4,5-TETRAHYDRO-2H-[2]-BENZAZEPIN-3-ONE
|
148842-86-8
|
C17H22N2O5
|
|
N-(2-ACETYL-4,5-DIMETHOXY-PHENYL)-ACETAMIDE
|
148842-95-9
|
C12H15NO4
|
|
Acetamide, N-[2-(1-hydroxy-2-propynyl)phenyl]- (9CI)
|
148842-98-2
|
C11H11NO2
|
|
7-Amino-3-methylphthalide
|
148843-77-0
|
C9H9NO2
|
|
|
synaptic vesicle membrane protein 2
|
148845-93-6
|
|
|
Ivabradine hydrochloride
|
148849-67-6
|
C27H37ClN2O5
|
|
ent-Ivabradine Hydrochloride
|
148849-68-7
|
C27H37ClN2O5
|
|
PROTEIN TYROSINE PHOSPHATASE SUBSTRATE I
|
148851-08-5
|
C44H68N11O21P
|
|
1-Propanone, 1-(2-acetylcyclopropyl)-2,2-dimethyl- (9CI)
|
148853-00-3
|
C10H16O2
|
|
2-(TRIFLUOROMETHYL)QUINOXALINE
|
148853-42-3
|
C9H5F3N2
|
|
Benzene, 1-bromo-3-isocyano- (9CI)
|
148854-09-5
|
C7H4BrN
|
|
(2,4-DIFLUOROPHENYL)TRIMETHYLSILANE
|
148854-10-8
|
C9H12F2Si
|
|
Pyrimidine,5-(trimethylsilyl)-(9CI)
|
148854-13-1
|
C7H12N2Si
|
|
1H-1,2,4-Triazole, 1,1'-(1,3-propanediyl)bis-
|
148854-47-1
|
C7H10N6
|
|
3(2H)-Indolizinone,7-fluorohexahydro-,cis-(9CI)
|
148855-27-0
|
C8H12FNO
|
|
3(2H)-Indolizinone,7-fluorohexahydro-,trans-(9CI)
|
148855-30-5
|
C8H12FNO
|
|
IN1637, Thiophene, 3-(pentyloxy)-
|
148855-96-3
|
C9H14OS
|
|
(S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione
|
148857-42-5
|
C11H10ClNO3
|
|
tert-Butyl 3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate
|
148858-04-2
|
C13H16N2O3
|
|
Ethyl 4,5-dihydroimidazo[1,5-a]quinoxaline-3-carboxylate
|
148858-09-7
|
C13H13N3O2
|
|
1,1,3,3-TETRACHLORO-1,3-DISILABUTANE
|
148859-49-8
|
C2H6Cl4Si2
|
|
3-VinylMorpholine
|
148860-48-4
|
C6H11NO
|
|
Triethylborane-1,3-diaminopropane
|
148861-07-8
|
C9H25BN2
|
|
ML 10302
|
148868-55-7
|
C15H21ClN2O3
|
|
YM 511
|
148869-05-0
|
C16H12BrN5
|
|
Benzenemethanamine, 5-fluoro-2-methoxy- (9CI)
|
148870-38-6
|
C8H10FNO
|
|
demethoxyeleutherol
|
148870-43-3
|
C13H10O3
|
|
(3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester
|
148870-55-7
|
C14H19NO4
|
|
Bicyclo[4.2.0]octa-1,3,5-triene-7-MethanaMine, 3,4-diMethoxy-N-Methyl-
|
148870-56-8
|
C12H17NO2
|
|
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one
|
148870-57-9
|
C15H18INO3
|
|
Ivabradin D6
|
148870-59-1
|
C27H36N2O5
|
|
2-BENZYLOXY-3-FLUOROBENZALDEHYDE
|
148872-79-1
|
C14H11FO2
|
|
1-Cyclohexene-1-carboxylic acid, 4-hydroxy- (9CI)
|
148874-23-1
|
C7H10O3
|
|
Methyl 5-fluoro-2,6-dihydroxynicotinate
|
148874-68-4
|
C7H6FNO4
|
|
2-BROMO-5-NAPHTHALEN-1-YL-THIOPHENE
|
148875-82-5
|
C14H9BrS
|
|
7-Chloro-2,4-dinitroxanthen-9-one
|
148877-20-7
|
C13H5ClN2O6
|
|
|
2-Propenoic acid, 2-methyl-, C2-18-alkyl esters, polymers with .alpha.-fluoro-.omega.-[2-[(1-oxo-2-propenyl)oxy]ethyl]poly(difluoromethylene) and vinylidene chloride
|
148878-17-5
|
|
|
|
7-((2-((Aminocarbonyl)amino-4-((4-chloro-6-(methyl(3(or 4)-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)phenyl)azo)-1,3,6-naphthalene trisulfonic acid sodium salt
|
148878-18-6
|
|
|
1,5-Naphthalenedisulfonic acid, 2-6-4-chloro-6-3-4-chloro-6-6-(1,5-disulfo-2-naphthalenyl)azo-5-hydroxy-1,7-disulfo-2-naphthalenylamino-1,3,5-triazin-2-ylaminophenylmethylmethylamino-1,3,5-triazin-2-ylamino-1-hydroxy-3,5-disulfo-2-naphthalenylazo-, sodium
|
148878-21-1
|
C54H39Cl2N14NaO26S8
|
|
tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate
|
148878-22-2
|
|
|
|
Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 2,2-dimethyl-1,3-propanediol, diphenyl carbonate, 1,6-hexanediol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and 1,1-methylenebis4-isocyanatocyclohexane, polyethylene-po
|
148878-27-7
|
|
|
|
Ambersorb(R) 563
|
148879-45-2
|
|
|
|
dehydrodolichol
|
148879-95-2
|
|
|
|
ginsenan PA
|
148880-10-8
|
|
|
|
POLYQUATERNIUM-29
|
148880-30-2
|
|
|
BENZYL-THIOPHEN-2-YLMETHYL-AMINE
|
148883-56-1
|
C12H13NS
|
|
2-((4-phosphopentamanniminophenyl)ethyl)-4-azidosalicylamide
|
148886-18-4
|
C45H69KN5O30P
|
|
8-Methoxyquinoline-4-carboxylic acid
|
148887-46-1
|
C11H9NO3
|
|
2-(3,4-DICHLORO-PHENYL)-QUINOLINE-4-CARBOXYLIC ACID
|
148887-61-0
|
C16H9Cl2NO2
|
|
1-(2-fluorophenyl)-2-methylpiperazine
|
148888-23-7
|
C11H15FN2
|
|
1,2-anhydro-3,4,6-tri-O-benzyltalopyranose
|
148888-66-8
|
C27H28O5
|
|
4-FLUOROBENZYLISOCYANIDE
|
148890-53-3
|
C8H6FN
|
|
5-AMINO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
|
148890-63-5
|
C8H8N2O2
|
|
8-Amino-1H-benzo[d][1,3]oxazin-2(4H)-one
|
148890-67-9
|
C8H8N2O2
|
|
RP 48497 (Eszopiclone Impurity C)
|
148891-53-6
|
C11H7ClN4O
|
|
5'-GUANYLYLIMIDODIPHOSPHATE TRISODIUM
|
148892-91-5
|
C10H18N6NaO13P3
|
|
HATU
|
148893-10-1
|
C10H15F6N6OP
|
|
FMOC-ARG(ALOC)2-OH
|
148893-34-9
|
C29H32N4O8
|
|
Methyl4-chloro-2-fluoroBenzoate
|
148893-72-5
|
C8H6ClFO2
|
|
Bis(10-hydroxybenzo[h]quinolinato)beryllium
|
148896-39-3
|
C26H16BeN2O2
|
|
1,3-Benzodioxole,2-ethoxy-5-nitro-(9CI)
|
148899-12-1
|
C9H9NO5
|
|
4H-1,3-Benzoxathiin-6-amine,2-ethoxy-(9CI)
|
148899-60-9
|
C10H13NO2S
|
|
3-Furancarboxamide,N-methoxy-N-methyl-(9CI)
|
148900-66-7
|
C7H9NO3
|
|
4-Pyridinemethanamine,2-methoxy-(9CI)
|
148900-69-0
|
C7H10N2O
|
|
N-(2-CYANO-3-FLUOROPHENYL)PYRROLE
|
148901-51-3
|
C11H7FN2
|
|
2-FLUORO-6-[4-(METHYLTHIO)PHENOXY]BENZONITRILE
|
148901-52-4
|
C14H10FNOS
|
|
3-CYANO-4-DIMETHYLAMINO-2-FLUOROBENZALDEHYDE
|
148901-53-5
|
C10H9FN2O
|
|
(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal
|
148901-68-2
|
C21H16FNO
|
|
Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate
|
148901-69-3
|
C27H26FNO4
|
|
2-Pyrrolidinethione, 1-(2-diazo-1,3-dioxobutyl)- (9CI)
|
148902-19-6
|
C8H9N3O2S
|
|
Bexlosteride.
|
148905-78-6
|
C14H16ClNO
|
|
Formaldehyde, polymer with 1,3-benzenediol, sodium salt
|
148906-95-0
|
C7H7NaO3
|
|
S-15176 DIFUMARATE SALT
|
148913-55-7
|
C31H48N2O4S.2C4H4O4
|
|
GFRGDGQ
|
148913-98-8
|
C30H45N11O11
|
|
ALA-LYS-GLU-ARG-LEU-GLU-ALA-LYS-HIS-ARG-GLU-ARG-MET-SER-GLN-VAL-MET
|
148914-01-6
|
C86H151N31O26S2
|
|
AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407)
|
148914-08-3
|
C25H47N11O9S
|
|
N-butyloxycarbonyl-phenylalanyl--dehydroaminobutyryl-NH-CH3
|
148914-46-9
|
C19H27N3O4
|
|
isodecyl 5-hydroxyanthranilate
|
148915-76-8
|
C17H27NO3
|
|
isoundecyl 5-hydroxyanthranilate
|
148915-77-9
|
C18H29NO3
|
|
isolauryl 5-hydroxyanthranilate
|
148915-78-0
|
C19H31NO3
|
|
Treprostinil Acyl-β-D-Glucuronide
|
148916-53-4
|
C29H42O11
|
|
|
Sodium Benzotriazole
|
148918-02-9
|
|
|
2,2'-Bioxazole, 4,4',5,5'-tetrahydro-4,4'-bis(1-methylethyl)-, (4R,4'R)-
|
148925-97-7
|
C12H20N2O2
|
|
(4R,4'R)-4,4',5,5'-Tetrahydro-4,4'-diphenyl-2,2'-bioxazole
|
148925-98-8
|
C18H16N2O2
|
|
MF 5137
|
148927-23-5
|
C23H23N3O3
|
|
L-368,899hydrochloride
|
148927-60-0
|
C26H42N4O5S2
|
|
4-(methylsulfonyl)Butanoic acid
|
148928-08-9
|
C5H10O4S
|